Experimental MERS treatment shows broad potential in trial
by Press Release from Outbreak News Today on (#3CZE9)
An experimental treatment developed from cattle plasma for Middle East respiratory syndrome (MERS) coronavirus infection shows broad potential, according to a small clinical trial led by National Institutes of Health scientists and their colleagues. The treatment, SAB-301, was safe and well tolerated by healthy volunteers, with only minor reactions documented. The first confirmed case of ["]
The post Experimental MERS treatment shows broad potential in trial appeared first on Outbreak News Today.